Sanofi-Aventis eyes growth in vaccine business
Sanofi-Aventis intends to double its vaccine business in the next five years with the aid of its Asian operations and partnerships, CEO Chris Viehbacher told German newspaper Frankfurter Allgemeine Zeitung. Viehbacher said Sanofi's vaccine unit will post an increase in sales of 15% to 16% if expansion plans push through.
Reuters | 10/31
This story published in BIO SmartBrief on 11/02/2009
More from SmartBrief:
Sanofi-Aventis is seeking biotech partners, CEO says:
Wednesday, November 11, 2009
Tolero secures global rights to U. of Georgia's bio-oil technology
Wednesday, September 16, 2009
Most execs to come from Merck after merger with Schering
Tuesday, September 1, 2009
Get stories like these delivered daily for FREE:
|
BIO SmartBrief
Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more |
|